Born from the desire to minimize inputs while maximizing performance, Ductal® stands for optimal strength, ductility and durability. For more than 25 years, we’ve been producing the most advanced range of Ultra High Performance Concrete technologies and services.

25年来，我们坚持不懈地提供最先进的超高性能混凝土技术和服务。为了最大限度地提高性能，同时减少投入，我们成功研发了Ductal®，它代表着最佳的强度、延展性和耐久性。

2023年2月27日 · Ductal carcinoma in situ (DCIS), or intraductal carcinoma, is a non-invasive breast cancer characterized by a proliferation of abnormal epithelial cells confined within the basement membrane. Disruption of the basement membrane layer would change the diagnosis from DCIS to invasive breast cancer.

About 1 in 5 new breast cancers will be ductal carcinoma in situ (DCIS). Nearly all women with this early stage of breast cancer can be cured. DCIS is also called intraductal carcinoma or stage 0 breast cancer. DCIS is a non-invasive or pre-invasive breast cancer.

2024年11月22日 · Ductal carcinoma in situ (DCIS) is a common form of breast cancer, accounting for approximately 20-25% of all new breast cancer cases in the United States. DCIS is a non-invasive cancer where abnormal cells have been found in the lining of the breast milk ducts .

乳腺导管原位癌（Ductal carcinoma in situ，簡稱DCIS） ，也称为乳腺管原位癌或乳管內原位癌，是發生在乳房的癌前（pre-cancerous）病變或非侵袭性癌症 [1] [2] 。 DCIS在 乳癌階段 （ 英语 ： Breast cancer classification ） 中歸類为階段0 [3] 。 乳腺导管原位癌很少會有症状，也沒有可感覺到的腫塊，通常是通过钼 ...

乳腺导管内原位癌（ductal carcinoma in situ, DCIS）外科治疗包括：肿瘤单纯切除术和全乳房切除。 全乳房切除术是DCIS根治性治疗手段，大约98%～99%患者接受这一手术治疗1，2。

Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes. Journal of the National Cancer Institute , 102(3), 170-178.

Learn about invasive ductal carcinoma and how BCRF investigators are driving advances in prevention, treatment, and more. Invasive ductal carcinoma, also called infiltrating ductal carcinoma (IDC) and invasive ductal breast cancer, is the most common type of breast cancer followed by invasive lobular carcinoma (ILC). Incidence rates of invasive ductal carcinoma have increased over the past 20 ...

2023年10月6日 · Ductal carcinoma in situ (DCIS) represents 18% to 25% of all diagnosed breast cancers, and is a noninvasive, nonobligate precursor lesion to invasive cancer. The diagnosis of DCIS represents a wide range of disease, including lesions with both low and high risk of progression to invasive cancer and recurrence.